CN111298055A - 一种渗透力强的两性用中药洗液及其制备方法 - Google Patents
一种渗透力强的两性用中药洗液及其制备方法 Download PDFInfo
- Publication number
- CN111298055A CN111298055A CN201811515435.4A CN201811515435A CN111298055A CN 111298055 A CN111298055 A CN 111298055A CN 201811515435 A CN201811515435 A CN 201811515435A CN 111298055 A CN111298055 A CN 111298055A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- amphoteric
- chinese medicine
- lotion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006210 lotion Substances 0.000 title claims abstract description 52
- 239000003814 drug Substances 0.000 title claims abstract description 45
- 230000035699 permeability Effects 0.000 title abstract description 13
- 238000002360 preparation method Methods 0.000 title description 10
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims abstract description 30
- 241000018646 Pinus brutia Species 0.000 claims abstract description 30
- 235000011613 Pinus brutia Nutrition 0.000 claims abstract description 30
- 238000000605 extraction Methods 0.000 claims abstract description 28
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims abstract description 26
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 claims abstract description 26
- 235000006679 Mentha X verticillata Nutrition 0.000 claims abstract description 25
- 235000002899 Mentha suaveolens Nutrition 0.000 claims abstract description 25
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims abstract description 25
- 244000305267 Quercus macrolepis Species 0.000 claims abstract description 25
- 235000016976 Quercus macrolepis Nutrition 0.000 claims abstract description 25
- 244000223014 Syzygium aromaticum Species 0.000 claims abstract description 25
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims abstract description 25
- 241000893536 Epimedium Species 0.000 claims abstract description 24
- 235000018905 epimedium Nutrition 0.000 claims abstract description 24
- 239000002994 raw material Substances 0.000 claims abstract description 22
- 239000000341 volatile oil Substances 0.000 claims abstract description 19
- 241000218176 Corydalis Species 0.000 claims abstract description 18
- 244000261559 Smilax china Species 0.000 claims abstract description 17
- 235000000485 Smilax china Nutrition 0.000 claims abstract description 17
- 240000009022 Smilax rotundifolia Species 0.000 claims abstract description 17
- 235000003205 Smilax rotundifolia Nutrition 0.000 claims abstract description 17
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 13
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 13
- 235000017443 Hedysarum boreale Nutrition 0.000 claims abstract description 13
- 235000007858 Hedysarum occidentale Nutrition 0.000 claims abstract description 13
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims abstract description 13
- 239000000203 mixture Substances 0.000 claims abstract description 7
- 239000000706 filtrate Substances 0.000 claims description 28
- 241000207925 Leonurus Species 0.000 claims description 25
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 24
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 15
- 230000010355 oscillation Effects 0.000 claims description 14
- 241000245665 Taraxacum Species 0.000 claims description 12
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 12
- 239000001569 carbon dioxide Substances 0.000 claims description 10
- 238000000194 supercritical-fluid extraction Methods 0.000 claims description 10
- 238000004821 distillation Methods 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 238000002791 soaking Methods 0.000 claims description 8
- 230000001954 sterilising effect Effects 0.000 claims description 8
- 238000004659 sterilization and disinfection Methods 0.000 claims description 8
- 238000009210 therapy by ultrasound Methods 0.000 claims description 8
- 238000000874 microwave-assisted extraction Methods 0.000 claims description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 6
- 229910052799 carbon Inorganic materials 0.000 claims description 6
- 241000196324 Embryophyta Species 0.000 claims description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 4
- 238000005238 degreasing Methods 0.000 claims description 4
- 239000012153 distilled water Substances 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 239000012259 ether extract Substances 0.000 claims description 4
- 239000000835 fiber Substances 0.000 claims description 4
- 239000012634 fragment Substances 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 230000003301 hydrolyzing effect Effects 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 239000003208 petroleum Substances 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 4
- 238000010298 pulverizing process Methods 0.000 claims description 4
- 238000003815 supercritical carbon dioxide extraction Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 23
- 206010061218 Inflammation Diseases 0.000 abstract description 11
- 230000004054 inflammatory process Effects 0.000 abstract description 11
- 241000212948 Cnidium Species 0.000 abstract description 10
- 241001180876 Saposhnikovia Species 0.000 abstract description 10
- 235000013399 edible fruits Nutrition 0.000 abstract description 10
- 241000913745 Spatholobus Species 0.000 abstract description 8
- 201000010099 disease Diseases 0.000 abstract description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 7
- 235000010894 Artemisia argyi Nutrition 0.000 abstract description 6
- 244000030166 artemisia Species 0.000 abstract description 6
- 230000002265 prevention Effects 0.000 abstract description 6
- 239000004480 active ingredient Substances 0.000 abstract description 5
- 208000015181 infectious disease Diseases 0.000 abstract description 5
- 230000036299 sexual function Effects 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 208000016599 Uterine disease Diseases 0.000 abstract description 3
- 230000036541 health Effects 0.000 abstract description 3
- 239000012466 permeate Substances 0.000 abstract description 3
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 3
- 208000013464 vaginal disease Diseases 0.000 abstract description 3
- 230000000857 drug effect Effects 0.000 abstract description 2
- 240000007890 Leonurus cardiaca Species 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 12
- 208000002193 Pain Diseases 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- 208000004145 Endometritis Diseases 0.000 description 5
- 208000006374 Uterine Cervicitis Diseases 0.000 description 5
- 206010046914 Vaginal infection Diseases 0.000 description 5
- 201000008100 Vaginitis Diseases 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 206010008323 cervicitis Diseases 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 210000003899 penis Anatomy 0.000 description 5
- 230000001568 sexual effect Effects 0.000 description 5
- 208000002003 vulvitis Diseases 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 208000019255 Menstrual disease Diseases 0.000 description 3
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 201000001881 impotence Diseases 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 108010059892 Cellulase Proteins 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 2
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 2
- 102000003960 Ligases Human genes 0.000 description 2
- 108090000364 Ligases Proteins 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 208000037093 Menstruation Disturbances Diseases 0.000 description 2
- 206010027339 Menstruation irregular Diseases 0.000 description 2
- 108010059820 Polygalacturonase Proteins 0.000 description 2
- 206010049677 Salpingo-oophoritis Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 229940106157 cellulase Drugs 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 108010093305 exopolygalacturonase Proteins 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 210000004392 genitalia Anatomy 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- IRHTZOCLLONTOC-UHFFFAOYSA-N hexacosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCO IRHTZOCLLONTOC-UHFFFAOYSA-N 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 230000001506 immunosuppresive effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000007102 metabolic function Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000018052 penile erection Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 206010036596 premature ejaculation Diseases 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000084 Abdominal pain lower Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012741 Diarrhoea haemorrhagic Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 206010056254 Intrauterine infection Diseases 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- FURUXTVZLHCCNA-UHFFFAOYSA-N Liquiritigenin Natural products C1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-UHFFFAOYSA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000036626 Mental retardation Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 208000005107 Premature Birth Diseases 0.000 description 1
- 206010036590 Premature baby Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 208000019802 Sexually transmitted disease Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193990 Streptococcus sp. 'group B' Species 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046793 Uterine inflammation Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 206010047799 Vulvovaginitis trichomonal Diseases 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000002814 agar dilution Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 150000001450 anions Chemical group 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000004097 bone metabolism Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 150000002306 glutamic acid derivatives Chemical class 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- -1 hydroxyl free radical Chemical class 0.000 description 1
- TZJALUIVHRYQQB-XLRXWWTNSA-N icariin Chemical compound C1=CC(OC)=CC=C1C1=C(O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)C(=O)C2=C(O)C=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-XLRXWWTNSA-N 0.000 description 1
- TZJALUIVHRYQQB-UHFFFAOYSA-N icariine Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(C)O2)O)C(=O)C2=C(O)C=C(OC3C(C(O)C(O)C(CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-UHFFFAOYSA-N 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- JBQATDIMBVLPRB-UHFFFAOYSA-N isoliquiritigenin Natural products OC1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 JBQATDIMBVLPRB-UHFFFAOYSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 208000027906 leg weakness Diseases 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- FURUXTVZLHCCNA-AWEZNQCLSA-N liquiritigenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-AWEZNQCLSA-N 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000003546 nucleic acid damage Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/49—Fagaceae (Beech family), e.g. oak or chestnut
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/234—Cnidium (snowparsley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/35—Extraction with lipophilic solvents, e.g. Hexane or petrol ether
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/55—Liquid-liquid separation; Phase separation
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明的渗透力强的两性用中药洗液使用柞树、松树、益母草、蛇床子、艾叶、鸡血藤、淫羊藿、延胡索,菝葜、薄荷、丁香、防风、炙甘草为原料,通过将上述的原料的配伍与提取,最大程度的发挥组合物有效成分,使洗液的渗透力加强,能有效渗透到病灶,对外阴疾病、阴道疾病、子宫疾病等妇科炎症有很好的预防和治疗效果;并且提高男性性功能,具有良好的保健功效;本发明的洗液使用的原料纯天然,无毒副作用,更加安全,使用放心。本发明含有的柞树和松树,针对各个原料的特性进行提取,能有效分离各组分的有效成分,将部分中药制备成精油,增加洗液中的有效成分的挥发和渗透作用,使各个成分的有效成分结合后,发挥更好的药效,使预防和治疗效果达到最佳。
Description
技术领域
本发明属于医药领域,具体地,涉及一种渗透力强的两性用中药洗液及其制备方法。
背景技术
妇科炎症是女性的常见疾病,主要是指女性生殖器官的炎症(外阴炎、阴道炎、宫颈炎、子宫炎、盆腔炎、附件炎、性传播疾病等),女性的生殖器官通常发生不同的急性和慢性炎症,在受到各种致病菌侵袭感染后发生的炎症。炎症不及时预防和治疗,除可能导致炎症在各生理部位相互蔓延和交叉感染外,会带来许多并发症,对免疫功能、新陈代谢以及内分泌系统都会产生不良影响,甚至导致某些部位的恶性病变。若是妊娠女性,可引起宫内感染、产道感染等影响新生儿,造成流产、早产、先天发育畸形、智力低下等严重后果。
现有的日常护理即使用中药洗液或西药作用;西药的作用较快,但毒副作用较大,大多中药洗液只是清除局部病菌,一般都是只是作用于阴部表面,不能彻底消灭细菌达到治愈炎症的效果。
一般洗液专门针对女性用户,通过洗液对女性进行日常护理,预防和治疗妇科疾病。忽视了性卫生不良,可能将细菌带入阴道里,进而引起子宫内膜炎、附件炎等生殖器官炎症,甚至有的人因输卵管发炎引起堵塞,还可能引起月经紊乱等问题。
经检索,同时用于两性的中药洗液并不多见。
发明内容
本发明针对上述问题,提供一种渗透力强的两性用中药洗液。本发明的渗透力强的两性用中药洗液使用柞树、松树、益母草、蛇床子、艾叶、鸡血藤、淫羊藿、延胡索,菝葜、薄荷、丁香、防风、炙甘草为原料,通过将上述的原料的配伍与提取,最大程度的发挥组合物有效成分,使洗液的渗透力加强,能有效渗透到病灶,对外阴疾病、阴道疾病、子宫疾病等妇科炎症有很好的预防和治疗效果;并且提高男性性功能,具有良好的保健功效;本发明的洗液使用的原料纯天然,无毒副作用,更加安全,使用放心。
本发明是通过以下技术方案实现的:
公开的渗透力强的两性用中药洗液,制成所述洗液有效成分的原料组成及重量份数为:柞树15~25份、松树10~15份、益母草3~6份、蛇床子6~12份、艾叶9~15份、鸡血藤8~16份、淫羊藿6~8份、延胡索2~5份,菝葜8~12份、薄荷5~8份、丁香8~10份、防风1~3份、炙甘草2~4份。
本发明的渗透力强的两性用中药洗液的制备方法,包括以下步骤:
S1.柞树的处理:将柞树的植物碎片加热至炭化,排出的气体经冷凝回收,静置2~3个月,取中层液体蒸馏,取105~110℃馏分的蒸馏液,滤纸过滤,取滤液一;
S2.松树的处理:将松树枝粉碎,用石油醚脱脂后加入水中,经浸泡、微波提取和超声振荡提取,过滤得到纤维渣;滤液经脱色、浓缩,得到松树提取物,静置分层后取中间澄清液,即为滤液二;
S3.采用蒸馏法,分别将益母草、淫羊藿、薄荷、蒲公英和丁香进行蒸馏,制备出相应的粗制精油;
S4.将所述的益母草、淫羊藿、薄荷、蒲公英和丁香的粗制精油分别进行二氧化碳超临界萃取一,得到纯度更高的二级精油;
S5.将蛇床子、艾叶份、鸡血藤、延胡索,菝葜、防风、炙甘草在40~50℃下进行水解,经超声波处理后,进行蒸馏处理回收初步提取液;
S6.再将初步提取液进行二氧化碳超临界萃取二,过滤,得到滤液三;
S7.将滤液三用乙醚萃取多次,收集乙醚萃取液,再加入无水硫酸钠干燥后,在50~75℃的水浴中回收乙醚,得到浓缩液;
S8.将滤液一、滤液二、二级精油和浓缩液用超声波震荡混合均匀,放置在灭菌箱内灭菌处理20~25分钟。
所述松树的克数与水的毫升数之比为1:6~9。
进一步地,步骤S1所述蒸馏液经活性炭吸附4~6小时,滤纸过滤3~6次。
进一步地,步骤S2所述微波提取的条件为:功率650W~780W微波提取5min~10min;所述超声振荡提取的条件为:功率80W~110W超声振荡提取20~30min。
进一步地,步骤S3所述的益母草、淫羊藿、薄荷、蒲公英和丁香的总质量与蒸馏水的质量比为1:20~25。
进一步地,步骤S4所述二氧化碳超临界萃取一的萃取压力20~40MPa,温度60~80℃,CO2流量2~5L/h,萃取时间100~120min。
进一步地,步骤S5所述超声波处理的频率为40~60KHz,功率为210~350W,处理5min~10min。
进一步地,步骤S6所述二氧化碳超临界萃取二的萃取压力20~40MPa,温度60~80℃,CO2流量2~5L/h,萃取时间100~120min。
进一步地,步骤S8所述超声波震荡采用频率为30~50MHz,处理5~10min。
本发明的柞树提取物治疗金黄色葡萄球菌或铜绿假单胞菌引起的人表皮炎症性、或感染性、或化脓性疾病具有一定的疗效。
本发明的松树提取物能延长维生素C在人体内的功效,激活维生素C和维生素E的作用,抑制脂蛋白氧化和羟自由基引起的核酸损伤,激活人体成长荷尔蒙的分泌,提高免疫反应和保护神经细胞免受由谷氨酸的盐、脂或其阴离子形式所引起的破坏,可以延缓衰老进程中出现的免疫力下降和血细胞新陈代谢功能衰退,并将它们恢复到正常水平。松树提取物能增加荷尔蒙分泌,延缓细胞衰老桦树提取物有细胞分裂素,促进细胞再生
益母草味辛苦、凉,活血、祛淤、调经、消水,治疗妇女月经不调,胎漏难产,胞衣不下,产后血晕,瘀血腹痛,崩中漏下,尿血、泻血,痈肿疮疡。
蛇床子燥湿,祛风,杀虫,温肾壮阳。用于阳痿、宫冷、寒湿带下、湿痹腰痛;外治外阴湿疹、妇人阴痒、滴虫性阴道炎。
艾叶用于外治皮肤瘙痒。
鸡血藤具有活血舒筋,养血调经的功效;主治风湿痹痛,月经不调,经行不畅,痛经,经闭,白细胞减少症。
淫羊藿益精气、强筋骨、补肾壮阳之要药,临床常用于治疗男子阳痿不举、滑精早泄、小便不禁以及女子不孕等症。淫羊藿含淫羊藿甙、挥发油、蜡醇、植物甾醇、鞣质、维生素E等成分。能兴奋性机能,对动物有促进精液分泌作用。药理实验研究表明,淫羊藿能增加心脑血管血流量,促进造血功能、免疫功能及骨代谢,具有抗衰老、抗肿瘤等功效。
延胡索:活血行气,调经止痛,主治妇人使气与血并,心腹作痛,或连腰胁,上下攻刺,经候不调,一切血气疼痛。
菝葜有抗炎、镇痛、抗肿瘤、抗氧化、免疫抑制等多种生物活性。
丁香对葡萄球菌、链球菌、大肠杆菌、伤寒杆菌、绿脓杆菌等有抑制作用。柴胡具有祛除寒邪之气、下气消食、润心肺、益气力、润肤、益精的功效,能治疗阳气下陷、月经不调、健忘等症。
防风具有祛风解表,胜湿止痛,止痉的功效。
含炙甘草有甘草素,它有助于平衡女性体内的激素含量。
菝葜有抗炎、镇痛、抗肿瘤、抗氧化、免疫抑制等多种生物活性。
相比现有技术,本发明的渗透力强的两性用中药洗液,具有以下优势:
本发明的渗透力强的两性用中药洗液使用柞树、松树、益母草、蛇床子、艾叶、鸡血藤、淫羊藿、延胡索,菝葜、薄荷、丁香、防风、炙甘草为原料,通过将上述的原料的配伍与提取,最大程度的发挥组合物有效成分,使洗液的渗透力加强,能有效渗透到病灶,对外阴疾病、阴道疾病、子宫疾病等妇科炎症有很好的预防和治疗效果;并且提高男性性功能,具有良好的保健功效;本发明的洗液使用的原料纯天然,无毒副作用,更加安全,使用放心。
本发明公开的渗透力强的两性用中药洗液含有的柞树,针对各个原料的特性进行提取,能有效分离各组分的有效成分,将部分中药制备成精油,增加洗液中的有效成分的挥发和渗透作用,使各个成分的有效成分结合后,发挥更好的药效,使预防和治疗效果达到最佳。
本发明公开的渗透力强的两性用中药洗液的中药组成物工艺制备过程简单,在反应过程中不会对环境产生任何有害物质,操作方便,且能耗低、污染少。
具体实施方式
下面结合具体实施例进一步说明本发明。除非特别说明,本发明实施例中采用的原料和方法为本领域常规市购的原料和常规使用的方法,所使用的设备为本领域常规设备。
本发明提供的渗透力强的两性用中药洗液,制成所述洗液有效成分的原料组成及重量份数为:柞树15~25份、松树10~15份、益母草3~6份、蛇床子6~12份、艾叶9~15份、鸡血藤8~16份、淫羊藿6~8份、延胡索2~5份,菝葜8~12份、薄荷5~8份、丁香8~10份、防风1~3份、炙甘草2~4份。
实施例1
本实施例提供的渗透力强的两性用中药洗液,制成的洗液有效成分的原料组成及重量份数为:柞树15份、松树10份、益母草6份、蛇床子6份、艾叶15份、鸡血藤8份、淫羊藿6份、延胡索5份,菝葜8份、薄荷8份、丁香8份、防风3份、炙甘草2份。
具体制备包括以下步骤:
S1.柞树的处理:将柞树的植物碎片加热至炭化,排出的气体经冷凝回收,静置2~3个月,取中层液体蒸馏,取105~110℃馏分的蒸馏液,活性炭吸附4~6小时,滤纸过滤3~6次,取滤液一;
S2.松树的处理:将松树枝粉碎,用石油醚脱脂后加入水中,松树的克数与水的毫升数之比为1:9,经浸泡、微波提取和超声振荡提取,过滤得到纤维渣;滤液经脱色、浓缩,得到松树提取物,静置分层后取中间澄清液,即为滤液二;微波提取的条件为:功率650W微波提取5min;超声振荡提取的条件为:功率110W超声振荡提取20min。
S3.采用蒸馏法,分别将益母草、淫羊藿、薄荷、蒲公英和丁香进行蒸馏,益母草、淫羊藿、薄荷、蒲公英和丁香的总质量与蒸馏水的质量比为1:25,制备出相应的粗制精油;
S4.将益母草、淫羊藿、薄荷、蒲公英和丁香的粗制精油分别进行二氧化碳超临界萃取一,萃取压力20MPa,温度60℃,CO2流量5L/h,萃取时间100min,得到纯度更高的二级精油;
S5.将蛇床子、艾叶份、鸡血藤、延胡索,菝葜、防风、炙甘草在40~50℃下进行水解,具体为将本步骤的中药材加入足量水进行浸泡,浸泡时同时加入麦芽糖和糖苷合成酶,浸泡后的中药材经过煎煮法得到水溶液;水溶液冷却后加入糖苷水解酶(纤维素酶和果胶酶)在40~50℃进行水解反应得到水解溶液;经超声波处理后,超声波处理的频率为40KHz,功率为350W,处理5min,进行蒸馏处理回收初步提取液;
S6.再将初步提取液进行二氧化碳超临界萃取二,萃取压力20MPa,温度60℃,CO2流量3L/h,萃取时间100min。过滤,得到滤液三;
S7.将滤液三用乙醚萃取多次,收集乙醚萃取液,再加入无水硫酸钠干燥后,在50~75℃的水浴中回收乙醚,得到浓缩液;
S8.将滤液一、滤液二、二级精油和浓缩液用频率为30MHz超声波震荡5min混合均匀,放置在灭菌箱内灭菌处理20~25分钟。
实施例2
本实施例提供的渗透力强的两性用中药洗液,制成的洗液有效成分的原料组成及重量份数为:柞树25份、松树15份、益母草4份、蛇床子10份、艾叶10份、鸡血藤15份、淫羊藿8份、延胡索2份,菝葜10份、薄荷5份、丁香10份、防风2份、炙甘草4份。
具体制备包括以下步骤:
S1.柞树的处理:将柞树的植物碎片加热至炭化,排出的气体经冷凝回收,静置2~3个月,取中层液体蒸馏,取105~110℃馏分的蒸馏液,活性炭吸附4~6小时,滤纸过滤3~6次,取滤液一;
S2.松树的处理:将松树枝粉碎,用石油醚脱脂后加入水中,松树的克数与水的毫升数之比为1:6,经浸泡、微波提取和超声振荡提取,过滤得到纤维渣;滤液经脱色、浓缩,得到松树提取物,静置分层后取中间澄清液,即为滤液二;微波提取的条件为:功率780W微波提取8min;超声振荡提取的条件为:功率80W超声振荡提取25min。
S3.采用蒸馏法,分别将益母草、淫羊藿、薄荷、蒲公英和丁香进行蒸馏,益母草、淫羊藿、薄荷、蒲公英和丁香的总质量与蒸馏水的质量比为1:20,制备出相应的粗制精油;
S4.将益母草、淫羊藿、薄荷、蒲公英和丁香的粗制精油分别进行二氧化碳超临界萃取一,萃取压力40MPa,温度80℃,CO2流量3L/h,萃取时间120min,得到纯度更高的二级精油;
S5.将蛇床子、艾叶份、鸡血藤、延胡索,菝葜、防风、炙甘草在40~50℃下进行水解,具体为将本步骤的中药材加入足量水进行浸泡,浸泡时同时加入麦芽糖和糖苷合成酶,浸泡后的中药材经过煎煮法得到水溶液;水溶液冷却后加入糖苷水解酶(纤维素酶和果胶酶)在40~50℃进行水解反应得到水解溶液;经超声波处理后,超声波处理的频率为60KHz,功率为250W,处理8min,进行蒸馏处理回收初步提取液;
S6.再将初步提取液进行二氧化碳超临界萃取二,萃取压力30MPa,温度80℃,CO2流量5L/h,萃取时间120min。过滤,得到滤液三;
S7.将滤液三用乙醚萃取多次,收集乙醚萃取液,再加入无水硫酸钠干燥后,在50~75℃的水浴中回收乙醚,得到浓缩液;
S8.将滤液一、滤液二、二级精油和浓缩液用频率为50MHz超声波震荡10min混合均匀,放置在灭菌箱内灭菌处理20~25分钟。
实施例3
本实施例提供的渗透力强的两性用中药洗液,制成的洗液有效成分的原料组成及重量份数为:柞树20份、松树12份、益母草6份、蛇床子8份、艾叶10份、鸡血藤15份、淫羊藿8份、延胡索2份,菝葜10份、薄荷5份、丁香10份、防风2份、炙甘草4份。
具体制备方法基本与实施例1相同,其不同之处在于步骤S2微波提取的条件为:功率700W微波提取5min;超声振荡提取的条件为:功率90W超声振荡提取20min。其余步骤与实施例1相同。
对比例1
本对比例提供的渗透力强的两性用中药洗液,制成所述洗液有效成分的原料组成及重量份数为:柞树10份、松树8份、益母草6份、蛇床子6份、艾叶15份、鸡血藤8份、淫羊藿6份、延胡索5份,菝葜8份、薄荷8份、丁香8份、防风3份、炙甘草2份。具体操作步骤与实施例1相同。
对比例2
本对比例提供的渗透力强的两性用中药洗液,制成所述洗液有效成分的原料组成及重量份数为:柞树30份、松树18份、益母草6份、蛇床子6份、艾叶15份、鸡血藤8份、淫羊藿6份、延胡索5份,菝葜8份、薄荷8份、丁香8份、防风3份、炙甘草2份。具体操作步骤与实施例1相同。
对比例3
本对比例提供的渗透力强的两性用中药洗液,制成所述洗液有效成分的原料组成及重量份数为:益母草6份、蛇床子6份、艾叶15份、鸡血藤8份、淫羊藿6份、延胡索5份,菝葜8份、薄荷8份、丁香8份、防风3份、炙甘草2份。即其原料中不添加柞树和松树,具体操作步骤与实施例1基本相同,去除关于柞树提取制备的步骤。
对比例4
本对比例提供的渗透力强的两性用中药洗液,制成的洗液有效成分的原料组成及重量份数为:柞树15份、松树10份、益母草6份、蛇床子6份、艾叶15份、鸡血藤8份、淫羊藿6份、延胡索5份,菝葜8份、薄荷8份、丁香8份、防风3份、炙甘草2份。其制备方法去除原步骤S3和S4,将所有的中药在40~50℃进行水解,超声蒸馏提取,其余制备方法与实施例1相同。
一、药理试验
1、抑菌试验
方法:琼脂稀释法
将本发明渗透力强的两性用中药洗液用已融化的琼脂培养基作系列稀释,倾注成含不同药物浓度的平板培养基。同时设不加药液和含青霉素、链霉素的平板培养基各一个,分别作细菌正常生长对照和阳性药物对照。将接种试验菌液的平板置37℃培养箱内培养24小时,观察记录各菌株在不同药物浓度培养基的生长情况。本发明药物组合物抑制细菌生长的最低浓度即为最小抑菌浓度(MIC),用其表示药物的体外抑菌强度。结果见表1。
表1
注:“+”为有细菌生长
结果表明,本发明中药洗液对所试菌株都有不同程度抑制作用,尤其对绿脓杆菌、金黄色葡萄球菌、B族链球菌和大肠杆菌。
二、临床试验
1、临床资料:挑选100对夫妻病例,女性病例的年龄为30~52岁,男性病例的年龄为33~59岁。其中女性均具有不同程度的带下量多,黄白相间或黄色,外阴不适或瘙痒、疼痛。西医诊断为外阴炎,阴道炎、宫颈炎、盆腔炎、附件炎、子宫内膜炎。中医辨证属湿热蕴结或兼脾虚湿注型。男性则患有不同程度的阳痿早泄,病程6个月到3年。
2、诊断标准:
2.1女性诊断标准:1.小腹疼痛或少腹一侧或两侧疼痛;2.带下量多,色黄或白,呈脓性、水样,或携血丝,有臭秽气;3.腰骶酸痛;4.神疲肢软;5.阴痒或有痛感。
2.2男性诊断标准:持续反复不能达到或维持足够阴茎勃起以完成满意性生活,生殖器萎弱勃起障碍,或勃起不坚不能完成正常房事,或过早射精,常伴有头晕神疲,腰酸腿软等,或兼有心悸易惊,心烦失眠等。
3、治疗方法:夫妻双方每周用本发明的洗液1~2次,同房前使用清洗,三个月为一个疗程,共治疗3个疗程。
4、疗效评价:
男性:
治愈:阴茎勃起达到或维持足够阴茎勃起以完成满意性生活,并能控制射精时间。
好转:阴茎勃起达不到足够阴茎勃起,但控制时间比较短。
无效:阴茎勃起达不到完成性生活,即使能勃起,射精也无法控制。
女性
痊愈:女性诊断标准中的所有项的所有症状均有明显改善,并通过医生检查诊断无外阴炎,阴道炎、宫颈炎、盆腔炎、附件炎、子宫内膜炎等病症。
好转:女性诊断标准中的所有项的所有症状均有改善,并通过医生检查诊断外阴炎,阴道炎、宫颈炎、盆腔炎、附件炎、子宫内膜炎等病症较使用本发明的安全套前均有改善或好转。
无效:女性诊断标准中的所有项的所有症状均无改善,并通过医生检查诊断外阴炎,阴道炎、宫颈炎、盆腔炎、附件炎、子宫内膜炎等病症较使用本发明的安全套前均无改善或好转。
5、治疗效果见下表2
表2
本发明通过上述实施例来说明本发明的详细工艺设备和工艺步骤,本领域技术人员应该了解,本发明不受上述实施例限制,上述实施例和说明书中描述的只是说明本发明的原理,在不脱离本发明精神和范围的前提下,本发明还会有各种变化和改进,这对本领域技术人员而言是显而易见的,这些变化和改进都落入要求保护的本发明范围内。
Claims (10)
1.一种渗透力强的两性用中药洗液,其特征在于:制成所述洗液有效成分的原料组成及重量份数为:柞树15~25份、松树10~15份、益母草3~6份、蛇床子6~12份、艾叶9~15份、鸡血藤8~16份、淫羊藿6~8份、延胡索2~5份,菝葜8~12份、薄荷5~8份、丁香8~10份、防风1~3份、炙甘草2~4份。
2.一种根据权利要求1所述渗透力强的两性用中药洗液的制备方法,其特征在于,包括以下步骤:
S1.柞树的处理:将柞树的植物碎片加热至炭化,排出的气体经冷凝回收,静置2~3个月,取中层液体蒸馏,取105~110℃馏分的蒸馏液,滤纸过滤,取滤液一;
S2.松树的处理:将松树枝粉碎,用石油醚脱脂后加入水中,经浸泡、微波提取和超声振荡提取,过滤得到纤维渣;滤液经脱色、浓缩,得到松树提取物,静置分层后取中间澄清液,即为滤液二;
S3.采用蒸馏法,分别将益母草、淫羊藿、薄荷、蒲公英和丁香进行蒸馏,制备出相应的粗制精油;
S4.将所述的益母草、淫羊藿、薄荷、蒲公英和丁香的粗制精油分别进行二氧化碳超临界萃取一,得到纯度更高的二级精油;
S5.将蛇床子、艾叶份、鸡血藤、延胡索,菝葜、防风、炙甘草在40~50℃下进行水解,经超声波处理后,进行蒸馏处理回收初步提取液;
S6.再将初步提取液进行二氧化碳超临界萃取二,过滤,得到滤液三;
S7.将滤液三用乙醚萃取多次,收集乙醚萃取液,再加入无水硫酸钠干燥后,在50~75℃的水浴中回收乙醚,得到浓缩液;
S8.将滤液一、滤液二、二级精油和浓缩液用超声波震荡混合均匀,放置在灭菌箱内灭菌处理20~25分钟。
3.根据权利要求2所述渗透力强的两性用中药洗液,其特征在于,所述松树的克数与水的毫升数之比为1:6~9。
4.根据权利要求2所述渗透力强的两性用中药洗液,其特征在于,步骤S1所述蒸馏液经活性炭吸附4~6小时,滤纸过滤3~6次。
5.根据权利要求2所述渗透力强的两性用中药洗液,其特征在于,步骤S2所述微波提取的条件为:功率650W~780W微波提取5min~10min;所述超声振荡提取的条件为:功率80W~110W超声振荡提取20~30min。
6.根据权利要求2所述渗透力强的两性用中药洗液,其特征在于,步骤S3所述的益母草、淫羊藿、薄荷、蒲公英和丁香的总质量与蒸馏水的质量比为1:20~25。
7.根据权利要求2所述渗透力强的两性用中药洗液,其特征在于,步骤S4所述二氧化碳超临界萃取一的萃取压力20~40MPa,温度60~80℃,CO2流量2~5L/h,萃取时间100~120min。
8.根据权利要求2所述渗透力强的两性用中药洗液,其特征在于,步骤S5所述超声波处理的频率为40~60KHz,功率为210~350W,处理5min~10min。
9.根据权利要求2所述渗透力强的两性用中药洗液,其特征在于,步骤S6所述二氧化碳超临界萃取二的萃取压力20~40MPa,温度60~80℃,CO2流量2~5L/h,萃取时间100~120min。
10.根据权利要求2所述渗透力强的两性用中药洗液,其特征在于,步骤S8所述超声波震荡采用频率为30~50MHz,处理5~10min。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811515435.4A CN111298055A (zh) | 2018-12-12 | 2018-12-12 | 一种渗透力强的两性用中药洗液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811515435.4A CN111298055A (zh) | 2018-12-12 | 2018-12-12 | 一种渗透力强的两性用中药洗液及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111298055A true CN111298055A (zh) | 2020-06-19 |
Family
ID=71161356
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811515435.4A Pending CN111298055A (zh) | 2018-12-12 | 2018-12-12 | 一种渗透力强的两性用中药洗液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111298055A (zh) |
-
2018
- 2018-12-12 CN CN201811515435.4A patent/CN111298055A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103751310B (zh) | 一种治疗筋膜炎的中药外用制剂及其制备方法 | |
CN103751633B (zh) | 一种治疗下肢静脉曲张的中药组合物及其制备方法 | |
CN102526441B (zh) | 一种专治妇科炎症的中药冲洗液 | |
CN104147514A (zh) | 治疗颈椎病的中药组合物及其制备方法 | |
CN102178814B (zh) | 一种治疗滴虫性阴道炎的中药组合物及其制备方法 | |
CN102058715B (zh) | 一种治疗慢性前列腺炎的中药制剂及其制备方法 | |
CN100515443C (zh) | 治疗妇科炎症疾病药品及其制备方法 | |
CN105213941A (zh) | 一种用于治疗小儿腹泻的中药组合物及其制备方法 | |
CN102626505B (zh) | 基于中草药的按摩膏及其制备方法 | |
CN112022916A (zh) | 一种治疗产后身痛中药组合物、制剂及其制备方法和应用 | |
CN105232880A (zh) | 一种治疗母猪热毒壅盛型子宫炎的中药添加剂及其制备方法 | |
CN111298055A (zh) | 一种渗透力强的两性用中药洗液及其制备方法 | |
CN111298054A (zh) | 一种含柞树成分的资料妇科炎症的洗液及其制备方法 | |
CN111297962A (zh) | 一种预防和治疗妇科炎症的避孕套 | |
CN104825946A (zh) | 一种洁阴洗液及其制备方法 | |
CN103977279A (zh) | 一种治疗母猪子宫炎的中药添加剂及其制备方法 | |
CN104288518A (zh) | 一种治疗宫颈炎的中药组合物 | |
CN111298207A (zh) | 一种抗敏消炎多功能避孕套 | |
CN108853410A (zh) | 一种用于防治妇科疾病的中药药剂及其制备方法和应用 | |
CN102526390A (zh) | 一种治疗妇科阴道炎的中药制剂 | |
CN108721422B (zh) | 一种用于霉菌性阴道炎治疗的药物组合物及其制备方法 | |
CN101653572B (zh) | 有效治疗盆腔炎的中药灌肠组合物 | |
CN111297964A (zh) | 一种具有松树和桦树提取物的安全套 | |
CN105535853A (zh) | 一种临床护理上用于治疗褥疮的中药组合物 | |
CN104491327A (zh) | 一种用于治疗褥疮的喷雾药剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200619 |
|
WD01 | Invention patent application deemed withdrawn after publication |